Диссертация (1173317), страница 22
Текст из файла (страница 22)
- 2015.- Vol. 236, N 2. - P. 107-113.doi.org/10.1620/tjem.236.107.92. Kinugasa, S. Increased asymmetric dimethylarginine and enhanced inflammationare associated with impaired vascular reactivity in women with endometriosis / S.Kinugasa, K. Shinohara, A. Wakatsuki // Atherosclerosis. – 2011.
– Vol. 219. – Issue 2.– P. 784–788.93. Krishnan, A. V. Tissue-selective regulation of aromatase expression by calcitriol:implications for breast cancer therapy. / A.V. Krishnan, J. Moreno, J [et al.] //Endocrinology. 2010. – Vol. 151. – P. 32–42.94.
Kvaskoff, M. Endometriosis: a high-risk population for major chronic diseases? /M. Kvaskoff, F. Mu [et al.] // Hum Reprod Update. – 2015. Vol. 21, N 4. – P. 500-516.doi:10.1093/humupd/dmv013.95. Laskowska M. Altered Maternal Serum Matrix Metalloproteinases MMP-2,MMP-3, MMP-9, and MMP-13 in Severe Early- and Late-Onset Preeclampsia / L.132Marzena [et al.] // BioMed Research International. -2017. – Vol. 2017.
- Article ID6432426. https://doi.org/10.1155/2017/643242696. LeRoy, E.C. Undifferentiated connective tissue syndromes / E.C. LeRoy, H.R.Mariq, M.B. Kahaleh // Arthritis Rheum. – 1980. – N 23. – P. 341-343.97. Leyendecker, G. Adenomyosis and endometriosis. re-visiting their associationand further insights into the mechanisms of auto-traumatisation. An MRI study / G.Leyendecker [et al.] // Arch Gynecol Obstet. – 2015. – N 291. – P. 917–932.98. Liu, X. Vitamin D modulates PGE2 synthesis and degradation in human lungfibroblasts / X. Liu [et al.] // Am.
J. Respir. Cell Mol. Biol. – 2014. – N 50. – P. 40–5099. Maier, J. A. High concentrations of magnesium modulate vascular endothelialcell behaviour in vitro / J.A. Maier [et al.] // Biochim Biophys Acta. – 2004. – N 1. – P.6-12.100. Malemud, C. J.
Matrix metalloproteinase in health and disease:an overview / C.J.Malemud [et al.] // Front Biosci. – 2006. – N 11. – P. 1696-1701.101. Marbaix, E. The expression of interstitial collagenase in human endometrium iscontrolled by progesterone and by oestradiol and is related to menstruation / E. Marbaix[et al.] // Biochem. J. – 1995. – Vol. 305. – P. 1027–1030.102. Margreet P. Membrane-type matrix metalloproteinases and vascularization inhuman endometrium during the menstrual cycle /P.
Margreet [et al.] // Basic science ofreproductive medicine. – 2006. – Vol. 12, Issue 1. – P. 11–18https://doi.org/10.1093/molehr/gah257103. Marjoribanks, J. Nonsteroidal anti-inflammatory drugs for dysmenorrhea / J.Marjoribanks [et al.] // Cochrane Database of Systematic Reviews. – 2015. - Issue 7.Art. No.: CD001751. DOI: 10.1002/14651858.CD001751.pub3.104. Matrix metalloproteinase-9: many shades of function in cardiovascular disease /A.
Yabluchanskiy [et al.] // Physiology (Bethesda). – 2013. – Vol. 28, N 6. – P. 391403.105. Maybin, J.A. Inflammatory pathways in endometrial disorders / J.A. Maybin [etal.] // Mol Cell Endocrinol. – 2011. – N 35. – P. 42–51.133106. Menzies, F.M. The role of mast cells and their mediators in reproduction,pregnancy and labour / F.M. Menzies, M.C. Shepherd, R.J. Nibbs [et al.] // Hum ReprodUpdate.
– 2011. – Vol. 17, N 3. – P. 383–396107. Mina, A. Cholecalciferol for Primary Dysmenorrhea in a College aged Population- A Clinical Trial / A. Mina [et al.] // Journal of Biology and Today’s World. – 2015. –Vol. 4, N 2. – P. 54-57108. Mosca, M. Undifferentiated connective tissue diseases (UCTD): A review of theliterature and a proposal for preliminary classification criteria / M.
Mosca // Clinical andexperimental rheumatology. - 2013. – N 17. – P. 615-620109. Mousain-Bosc, M. Magesium VitB6 itake reduces central nervous systemhyperexcitability in children / M. Mousain-Bosc, M. Roche, J. Rapin // JournalAmerican College of Nutrition. - 2004. - Vol. 23, № 5. - P. 545-548.110.
Mrugacz, G. Etiopathogenesis of dysmenorrhea / G. Mrugacz [et al.] // MedWieku Rozwoj. – 2013. – Vol. 17, N 1. – P. 85-89.111. Murawala, H. Variation in expression and activity pattern of mmp2 and mmp9on different time scales in the regenerating caudal fin of Poecilia latipinna / H.Murawala // J Fish Biol. – 2018. – Vol. 92, N 5. – P. 1604-1619https://doi.org/10.1111/jfb.13618112. Narring, F.
Dysmenorrhea: a problem for the pediatrician? / F. Narring [et al.] //Arch Pediatr. – 2012. – Vol. 19, N 2. – P. 125-130. doi: 10.1016/j.arcped.2011.11.009.113. Naruse, K. Localization of matrix metalloproteinase (MMP-2), MMP-9 ang tissueinhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy /K. Naruse [et al.] // Human Reproduction. – 2009. – Vol.
24, N 3. – P. 553-561.114. Nasehi, M. Comparison of the effectiveness of combination of fennelextract/vitamin E with ibuprofen on the pain intensity in students with primarydysmenorrhea / M. Nasehi [et al.] // Iran. J. Nurs. Midwifery Res. - 2013. - Vol. 18, N 5.- P.
355–359.115. Noncontraceptive uses of hormonal contraceptives. ACOG, practice bulletinnumber 110 [Text] / Obstetrics and Gynaecology. - 2010. - Vol. 115, № 1. - P. 206-218.134116. Odukoya, O.A. Soluble CD23 in the peritoneal fluid of patients withendometriosis / O.A. Odukoya [et al.] // Hum. Reprod. - 1996. – N 11. – P. 2018–2121.117. Parazzini, F. Cigarette smoking, alcohol consumption, and risk of primarydysmenorrhea / F. Parazzini [et al.] // Epidemiology. – 1994. – Vol.
5, N 4. – P. 469–472.118. Pattanittum, P. Dietary supplements for dysmenorrhea / P. Pattanittum [et al.] //Cochrane Database of Systematic Reviews. – 2016. - Issue 3. - Art. No.: CD002124.DOI:10.1002/14651858.CD002124.pub2.119. Pepper, M.S. Extracellular proteolysis and angiogenesis / M.S. Pepper // ThrombHaemost. – 2001. - N 86. – P. 346–355.120. Poulopoulos, A.K.
Expression of matrix metalloproteinases 9 and 12 in actiniccheilitis / A.K. Poulopoulos, D. Andreadis, A.K. Markopoulos // World Journal ofExperimental Medicine. – 2013. – Vol. 3, N 3. – P. 43-49.121. Rees, M.C. Leukotriene release by endometrium and myometrium throughout themenstrual cycle in dysmenorrhoea and menorrhagia / M.C. Rees [et al.] // J. Endocrinol.– 1987. – N 113. – P. 291–295.122. Rocha, A.
L. Angiogenesis and endometriosis / A.L. Rocha [et al.] // ObstetGynecol Int. – 2013. - 859619. doi: 10.1155/2013/859619123. Ruljancic, N. Platelet serotonin and magnesium concentrations in suicidal andnon-suicidal depressed patients / N. Ruljancic [et al.] // Magnes Res. – 2013. – Vol. 26,N 1. – P. 9-17.
doi:10.1684/mrh.2013.0332.124. Saggese, G. Osteoporosis in children and adolescents: diagnosis, risk factors andprevention / G. Saggese, G.I. Baroncelli, S. Bertelloni // J. Pediatr. Endocrinol. Metab. –2011. – Vol. 14, N 7. – P. 833-859.125. Sakineh, M. Calcium With and Without Magnesium for Primary Dysmenorrhea:A Double-Blind Randomized Placebo-Controlled Trial / M. Sakineh [et al.] //International Journal of Women’s Health and Reproduction Sciences. – 2017. - Vol. 5,N 4.
– P. 332–338 doi:10.15296/ijwrs.2017.56.126. Sakineh, M. Effects of Calcium-Vitamin D and Calcium-Alone on Pain Intensityand Menstrual BloodLoss in Women with Primary Dysmenorrhea:A Randomized135Controlled Trial / M. Sakineh [et al.] // Pain Medicine. – 2017. – N 18. – P. 3–13doi:10.1093/pm/pnw121127. Sampson, J. A. Peritoneal endometriosis due to the menstrual dissemination ofendometrial tissues into the peritoneal cavity / J.A.
Sampson [et al.] // Am J ObstetGynecol. – 1927. – N 14. – P. 422–425.128. Samrichard, R. The balance of matrix metalloproteinase-2 (Mmp-2) and tissueinhibitor of matrix metalloproteinase-2 (Timp-2) on severe endometriosis / R.Samrichard [et al.] // Journal of Gynecology and Obstetrics. – 2015. – Vol. 3, N 6. – P.111-114 doi: 10.11648/j.jgo.20150306.12129. Sharan, C. VitaminD inhibits proliferation of human uterine leiomyoma cells viacatechol-Omethyltransferase / C. Sharan [et al.] // Fertil Steril. – 2011.
– N 95. – P.247–253.130. Sherif, B.Q. Effects of Some NonSteroidal Anti-inflammatory Drugs onOvulation in Women with Mild Musculoskeletal Pain (A Clinical Study) / B.Q. Sherif[et al.] // Journal of Pharmacy and Biological Sciences. – 2014. - Issue 4, Ver. IV. – P.43-49. www.iosrjournals.org131. Smith, C.A. Acupuncture for dysmenorrhea / C.A.
Smith [et al.] // CochraneDatabase Syst Rev. – 2016. – 4. - CD007854.132. Smith, S.K. Regulation of angiogenesis in the endometrium / S.K. Smith [et al.] //Trends Endocrinol Metab. - 2001. – Vol. 12. – P. 147–151.133. Strowitzki, T. Efficacy of ethinylestradiol 20 μg/drospirenone 3 mg in a flexibleextended regimen in women with moderate-to-severe primary dysmenorrhoea: an openlabel, multicentre, randomised, controlled study / T. Strowitzki [et al.] // J Fam PlannReprod Health Care. – 2012. – N 38. – P.
94–101. doi:10.1136/jfprhc-2011-100225134. Szymanowski, K A.Matrix metalloproteinase-2 (MMP-2), MMP-9, tissueinhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2(TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis/K. Szymanowski [et al.] // Ann Agric Environ Med. – 2016. – Vol.
23, N 4. – P. 649653.136135. Tavallaee, M. The prevalence of menstrual pain and associated risk factors amongIranian women / M. Tavallaee [et al.] // J Obstet Gynaecol Res. – 2011. – Vol. 37, N 5.– P. 442–451136. Tobinick, E. L. TNF inhibition for the treatment of pre-menstrual syndrome andprimary dysmenorrhea. Patent Application Publication (10) Pub.
No.: US 2003/0113318A1. (19) United States. Tobinick (43) Pub. Date: Jun. 19, 2003137. Tokuyama, S. Unsaturated fatty acids and pain / S. Tokuyama, K. Nakamoto //Biol. Pharm. Bull. – 2011. - N 34. – P. 1174-1178.138. Tu, C.H. Brain morphological changes associated with cyclic menstrual pain /C.H.
Tu [et al.] // Pain. – 2010. – N 150. – P. 462-468.139. Tu, C. H. Abnormal cerebral metabolism during menstrual pain in primarydysmenorrhea / C.H. Tu [et al.] // Neuroimage. – 2009. – N 47. – P. 28-35.140. Valentin, L. Effects of a vasopressin antagonist in women with dysmenorrhea /L.Valentin [et al.] // Gynecol Obstet Invest. – 2000. –N 50. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
